Life after patent: Drug price dynamics and cost-effectiveness analysis
View ORCID ProfileMiquel Serra-Burriel, Nicolau Martin-Bassols, Gellért Perényi, View ORCID ProfileKerstin N. Vokinger
doi: https://doi.org/10.1101/2023.06.08.23290510
Miquel Serra-Burriel
1Faculty of Law and Faculty of Medicine, University of Zurich, Zurich, Switzerland
2Epidemiology, Biostatistics, and Prevention Institute, University of Zurich, Zurich, Switzerland
Nicolau Martin-Bassols
3Centre for Health Economics, Monash University, Caulfield, Victoria, Australia
Gellért Perényi
1Faculty of Law and Faculty of Medicine, University of Zurich, Zurich, Switzerland
Kerstin N. Vokinger
1Faculty of Law and Faculty of Medicine, University of Zurich, Zurich, Switzerland
Data Availability
Data cannot be shared due to being property of IQVIA.
Posted June 12, 2023.
Life after patent: Drug price dynamics and cost-effectiveness analysis
Miquel Serra-Burriel, Nicolau Martin-Bassols, Gellért Perényi, Kerstin N. Vokinger
medRxiv 2023.06.08.23290510; doi: https://doi.org/10.1101/2023.06.08.23290510
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2779)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12428)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4295)
- Geriatric Medicine (397)
- Health Economics (704)
- Health Informatics (2775)
- Health Policy (1028)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (405)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4070)
- Nursing (218)
- Nutrition (603)
- Oncology (2148)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (78)
- Pathology (480)
- Pediatrics (1151)
- Primary Care Research (472)
- Public and Global Health (6675)
- Radiology and Imaging (1457)
- Respiratory Medicine (888)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)